NCT07023445
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +15 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
Clinical trial condition
Lipid Metabolism, Inborn Errors
Explore clinical trials studying Lipid Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.
834 public trials
155 recruiting studies
Lipid Metabolism, Inborn Errors trial results
NCT04628364
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +23 more
- Locations
-
- National Organization for Rare Disorders Danbury, Connecticut, United States
Completed
[68Ga]Ga-GZP PET for Early Response Prediction in Colorectal Cancer During Neoadjuvant Therapy
NCT06982053
- Conditions
- Colonic Diseases, Colorectal Cancer Control and Prevention, Colorectal Cancer Metastatic, +24 more
- Locations
-
- Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China. Wuhan, China
Completed
Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry
NCT03110432
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Dyslipoproteinemias, +14 more
- Locations
-
- Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Germany
- Innere Medizin IV - Diabetologie, Endokrinologie und Nephrologie am Universitaetsklinikum Tübingen, Germany
- Nephrologisches Zentrum Villingen-Schwenningen, Germany
Completed
A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease
NCT05398029
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +16 more
- Locations
-
- Clinical Study Center Auckland, New Zealand
- Clinical Study Center Christchurch, New Zealand
- Clinical Study Center London, United Kingdom
NCT03409744
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Clinical Trial Site Los Angeles, California, United States
- Clinical Trial Site Boca Raton, Florida, United States
- Clinical Trial Site Boston, Massachusetts, United States
- Clinical Trial Site New York, United States
Completed
Impact of Rosuvastatin Doses on LDL Levels, CPK Levels and Aspartate Aminotransferase Levels
NCT06910098
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Central Park Teaching Hospital Lahore, Pakistan
NCT03910621
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Peking University first Hospital Beijing, China
- Xin Hua Hospital, Shanghai Jiao Tong University Shanghai, China
Completed
Safety and Effectiveness of Evinacumab for the Treatment of Homozygous Familial Hypercholesterolemia
NCT05611528
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Ecogene-21 Saguenay, Quebec, Canada
NCT06007768
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +22 more
- Locations
-
- Hospital Universitario Ramón y Cajal Madrid, Spain